Lance C. Pagliaro

Also affiliated with WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer”.

A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer

European Journal of Cancer(2020)10.1016/j.ejca.2019.12.027

N/A

0.435DataRank · unranked

7 citations

Nicholas Spetsieris, Justin A. Weldon, Alexandros Tsikkinis, Anh Hoang, Ana M. Aparicio +14 more

Phase II Evaluation Of Stereotactic Ablative Radiotherapy (SABR) in 11C-Choline PET/CT (Cho-PET)-Identified Oligometastatic Castration-Resistant Prostate Cancer (CRPC)

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.07.429

N/A

0DataRank · unranked

0 citations

Feven Abraha, Bradley J. Stish, Val J. Lowe, Lance C. Pagliaro, C. Richard Choo +13 more

The international penile advanced cancer trial (InPACT): The first phase III trial for squamous carcinoma of the penis with regional lymph node metastases.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.tps7

N/A

0DataRank · unranked

15 citations

Steve Nicholson, Philippe E. Spiess, Lance C. Pagliaro, Nick Watkin, Jim Barber +13 more

Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration‐resistant prostate cancer

The Prostate(2023)10.1002/pros.24498

N/A

0DataRank · unranked

1 citations

Brian A. Costello, Fernando Quevedo, Lance C. Pagliaro, Cristobal T. Sanhueza, Richard M. Weinshilboum +6 more

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1917

N/A

0DataRank · unranked

2 citations

John F. Ward, Wayne L. Hofstetter, David C. Rice, José A. Karam, Louis L. Pisters +24 more

Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors

Journal of Pain and Symptom Management(2025)10.1016/j.jpainsymman.2025.04.016

N/A

0DataRank · unranked

2 citations

Miguel Muniz, Candy S Peskey, Aminah Jatoi, Kathryn J. Ruddy, Jacob J. Orme +14 more

A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2020.05.013

N/A

0DataRank · unranked

16 citations

Myrto Boukovala, Justin A. Weldon, Alexandros Tsikkinis, Anh Hoang, Ana M. Aparicio +15 more

Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis

European Urology Oncology(2025)10.1016/j.euo.2025.04.015

N/A

0DataRank · unranked

0 citations

Rebecca S. Tidwell, Brian F. Chapin, Deborah Harris, Miao Zhang, Louis L. Pisters +11 more